SB16 Alabama 2018 Session

Under existing law, there is no provision to allow for the administering of certain investigational stem cell treatments to patients with severe chronic diseases or terminal illnesses

This bill would provide for the availability of stem cell treatment options for certain patients with terminal illnesses or severe chronic illnesses under certain conditions

Amendment 621 of the Constitution of Alabama of 1901, now appearing as Section 111.05 of the Official Recompilation of the Constitution of Alabama of 1901, as amended, prohibits a general law whose purpose or effect would be to require a new or increased expenditure of local funds from becoming effective with regard to a local governmental entity without enactment by a 2/3 vote unless: it comes within one of a number of specified exceptions; it is approved by the affected entity; or the Legislature appropriates funds, or provides a local source of revenue, to the entity for the purpose

The purpose or effect of this bill would be to require a new or increased expenditure of local funds within the meaning of the amendment. However, the bill does not require approval of a local governmental entity or enactment by a 2/3 vote to become effective because it comes within one of the specified exceptions contained in the amendment

Relating to health; to provide for the availability of certain investigational stem cell treatments; to provide for informed consent; to specify treatment requirements; to provide for oversight by an institutional review board; to provide certain record keeping requirements; to provide criminal penalties for the purchase or sale of adult stem cells for certain investigational treatments; and in connection therewith would have as its purpose or effect the requirement of a new or increased expenditure of local funds within the meaning of Amendment 621 of the Constitution of Alabama of 1901, now appearing as Section 111.05 of the Official Recompilation of the Constitution of Alabama of 1901, as amended.